The initial implementation phase of myUABResearch, the university’s new electronic research administration system, is on ...

Patients with rare diseases are increasingly working to find and fund their own cures. But should they have to?

New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed up the process.

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

The clinical trials office will build on Manitoba’s strength as Canada’s second-largest pharmaceutical exporter and a hub for ...

A review of randomized clinical trials published in rheumatology from 2009 to 2023 found that just 39.8% of authors were women, and that women were less likely to be senior authors, according to data ...

The Nutrition Care Process (NCP) constitutes a systematic methodology that underpins clinical nutrition practice, guiding dietitians through comprehensive patient assessments, diagnosis ...

Automation and artificial intelligence are streamlining everything from regulatory tasks to clinical trials and drug ...

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...

Did you know that a small molecule called NAD+ plays a critical role in our aging process? A deficiency of this molecule may ...

In 1954, the world's first successful organ transplant took place at Brigham and Women's Hospital, in the form of a kidney donated from one twin to the other. At the time, a group of doctors and ...

Currently, PET scanner validation phantoms, methods, and acceptance criteria for clinical trials are not standardized. This situation generates substantial inefficiencies with many scanners being ...